EyeGate Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
MYOKMyoKardia, Inc. 0.09%223.531.8%$529.51m
HZNPHorizon Therapeutics Plc -3.59%74.935.8%$156.10m
VRXValeant Pharmaceuticals International, Inc. -2.08%16.5014.1%$97.09m
JAZZJazz Pharmaceuticals Plc -1.05%144.102.4%$73.67m
CTLTCatalent, Inc. -1.80%87.782.1%$69.26m
UTHRUnited Therapeutics Corp. 3.06%134.2314.1%$68.71m
BHCBausch Health Cos., Inc. -2.08%16.500.0%$59.77m
SAGESAGE Therapeutics, Inc. -0.72%73.388.6%$45.85m
ICLRICON plc -1.62%180.304.2%$42.06m
ARGXargenx SE -2.46%248.130.0%$35.01m
PRGOPerrigo Co. Plc 3.08%43.846.8%$32.61m
ENDPEndo International Plc -3.38%4.578.7%$30.02m
GWPHGW Pharmaceuticals Plc 0.76%90.016.2%$28.78m
AMRNAmarin Corp. Plc -1.22%4.861.5%$26.85m
ICPTIntercept Pharmaceuticals, Inc. -3.97%27.7916.8%$23.24m

Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.